-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Gilead Sciences, Raises Price Target to $151

Benzinga·12/12/2025 17:10:47
語音播報
Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $147 to $151.